Congrats👋🏽@yasar_caliskan for leadership of ‘#LIMS1 Gene and Risk of T-Cell Mediated #Rejection in #KidneyTransplant’, #KidneyWk2020 #esposter📲. 🙏🏽Grateful for international🇹🇷 🇺🇸collaboration incl: @smirioglu @_halilyazici #BurakDirim, #ErolDemir, #OzgurOto #AydinTurkmen. #ASN

Congrats👋🏽@yasar_caliskan for leadership of ‘#LIMS1 Gene and Risk of T-Cell Mediated #Rejection in #KidneyTransplant’, #KidneyWk2020 #esposter📲. 🙏🏽Grateful for international🇹🇷 🇺🇸collaboration incl: @smirioglu @_halilyazici #BurakDirim, #ErolDemir, #OzgurOto #AydinTurkmen. #ASN

Honored to co-moderate ‘Adapting Practice to a #Pandemic: Focus on #HomeDialysis & #KidneyTransplantation’ w/ @PD_Perls, @ASNKidney #KidneyWk2020 Re-imagined📲. 🙏🏽#EdwinaBrown #SusieLew @SumitMohanMD @EmilyBlumbergMD & @itsglendar for thoughtful perspectives on impact of #COVID19

Honored to co-moderate ‘Adapting Practice to a #Pandemic: Focus on #HomeDialysis & #KidneyTransplantation’ w/ @PD_Perls, @ASNKidney #KidneyWk2020 Re-imagined📲. 🙏🏽#EdwinaBrown #SusieLew @SumitMohanMD @EmilyBlumbergMD & @itsglendar for thoughtful perspectives on impact of #COVID19

AKI_CART therapy #kidneywk2020 @ShrutiGkidney @MegSise @AJKDonline and MSKCC experience @sloan_kettering @MGHKidneys

Cytokine release syndrome as as side effect of CAR-T therapy #kidneywk2020

#AKI after #CART therapy #kidneywk2020 John Hogan @PennKidney

PO2111 #kidneywk2020
Title: Efficacy and Safety of Roxadustat in Patients with Non-Dialysis-Dependent CKD, Anemia, and Heart Failure @sfishbane https://asn.apprisor.org/index.cfm?k=st9d4p9oro

PO2112 @sfishbane #kidneywk2020
Title: Efficacy and Safety of Roxadustat in Patients with Dialysis-Dependent CKD, Anemia, and Heart Failure https://asn.apprisor.org/index.cfm?k=du923tc43n

Great start to @ASNKidney #kidneywk2020 re-imagined! Check-out our poster on ‘Survey of U.S. #LivingKidneyDonation & #Transplant Practices in #COVID19 Era.’ The pandemic has broad impacts on #LDKT practice.🙏🏽Grateful to programs for #survey engagement & to study collaborators.

Great start to @ASNKidney #kidneywk2020 re-imagined! Check-out our poster on ‘Survey of U.S. #LivingKidneyDonation & #Transplant Practices in #COVID19 Era.’ The pandemic has broad impacts on #LDKT practice.🙏🏽Grateful to programs for #survey engagement & to study collaborators.

Shout out for our @KIReports paper on glomerular diseases seen with ICI therapy #kidneywk2020 #onconephrology @onconeph @renalmyeloma @hawkssox @SWadhwaniMD www.kireports.org/article/S2468-0249(20)31...

Pauci immune vasculitis with ICI therapy #kidneywk2020

Earlier data showing some Glomerular findings @MDAndersonNews #kidneywk2020

Leah H on glomerular disease findings with ICI #kidneywk2020 - some ATN that was reported @CKJsocial https://academic.oup.com/ckj/article/12/1/81/5168430

How do we treat ICI-AKI? #kidneywk2020 and re-challenge

PPIs and NSAIDS- risk factor for AKI- immunotherapy -#kidneywk2020

Do you biopsy AKI-Immunotherapy? #kidneywk2020 @MegSise

#kidneywk2020 on HELPS-HD

Protect trial next #kidneywk2020 ⁦⁦@gchertow⁩

Yes. Finally!! A real world data #kidneywk2020 Pontecelli works!! Lets stop the madness. Tac+ ritux not a bad idea either

The classic Pontecelli regimen works all the time - i have always had no issues #kidneywk2020

#kidneywk2020 more on sglt2i EMPEROR reduced

Next up https://www.nejm.org/doi/full/10.1056/NEJMoa2022190 #kidneywk2020 high impact 2020

#kidneywk2020 on FIDELO DKD. Amazing. Another positive trial ⁦@NEJM⁩ ⁦@ASNKidney⁩

High impact ⁦@AgarwalRajivMD⁩ on FIDELIO DKD #kidneywk2020

Doesn't matter cancer- kidney disease - bad outcomes @onconeph #kidneywk2020 #onconephrology

Using visual abstracts @nymurakami #kidneywk2020

Use of immunotherapy in transplant patients #kidneywk2020 @nymurakami @LVRiella @renalmyeloma @vinaynairdo

AMazing dramatic drop in proteinuria #kidneywk2020 #amyloidosis #daratumumab